Moderna Stock Falls Despite Vaccine Sales More Than Tripling From Last Year

Topline Shares of Moderna dropped on Wednesday even after the biotech company reported higher-than-expected revenue and profits in the first quarter, with results boosted by soaring coronavirus vaccin...